全文获取类型
收费全文 | 6877篇 |
免费 | 384篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 292篇 |
妇产科学 | 214篇 |
基础医学 | 730篇 |
口腔科学 | 157篇 |
临床医学 | 1200篇 |
内科学 | 981篇 |
皮肤病学 | 73篇 |
神经病学 | 521篇 |
特种医学 | 217篇 |
外科学 | 668篇 |
综合类 | 69篇 |
一般理论 | 11篇 |
预防医学 | 960篇 |
眼科学 | 100篇 |
药学 | 555篇 |
中国医学 | 13篇 |
肿瘤学 | 494篇 |
出版年
2023年 | 27篇 |
2022年 | 26篇 |
2021年 | 110篇 |
2020年 | 67篇 |
2019年 | 121篇 |
2018年 | 147篇 |
2017年 | 104篇 |
2016年 | 113篇 |
2015年 | 144篇 |
2014年 | 213篇 |
2013年 | 302篇 |
2012年 | 444篇 |
2011年 | 482篇 |
2010年 | 328篇 |
2009年 | 224篇 |
2008年 | 465篇 |
2007年 | 509篇 |
2006年 | 530篇 |
2005年 | 478篇 |
2004年 | 460篇 |
2003年 | 452篇 |
2002年 | 494篇 |
2001年 | 93篇 |
2000年 | 95篇 |
1999年 | 82篇 |
1998年 | 84篇 |
1997年 | 83篇 |
1996年 | 54篇 |
1995年 | 58篇 |
1994年 | 45篇 |
1993年 | 35篇 |
1992年 | 31篇 |
1991年 | 26篇 |
1990年 | 25篇 |
1989年 | 24篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 27篇 |
1985年 | 25篇 |
1984年 | 20篇 |
1983年 | 24篇 |
1982年 | 19篇 |
1981年 | 25篇 |
1980年 | 23篇 |
1979年 | 15篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 11篇 |
1974年 | 23篇 |
1973年 | 11篇 |
排序方式: 共有7319条查询结果,搜索用时 735 毫秒
91.
92.
Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. 总被引:5,自引:0,他引:5
Frederick P Li Jonathan A Fletcher Michael C Heinrich Judy E Garber Stephen E Sallan Clara Curiel-Lewandrowski Anette Duensing Matt van de Rijn Lowell E Schnipper George D Demetri 《Journal of clinical oncology》2005,23(12):2735-2743
PURPOSE: Members of a family with hereditary gastrointestinal stromal tumors (GISTs) and a germline KIT oncogene mutation were evaluated for other potential syndrome manifestations. A tumor from the proband was analyzed to compare features with sporadic GISTs. PATIENTS AND METHODS: Members of a kindred in which six relatives in four consecutive generations comprised an autosomal dominant pattern of documented GISTs and cutaneous lesions underwent physical examination, imaging studies, and germline KIT analysis. A recurrent GIST from the proband was studied using microarray, karyotypic, immunohistochemical, and immunoblotting techniques. RESULTS: In addition to evidence of multiple GISTs, lentigines, malignant melanoma, and an angioleiomyoma were identified in relatives. A previously reported gain-of-function missense mutation in KIT exon 11 (T --> C) that results in a V559A substitution within the juxtamembrane domain was identified in three family members. The proband's recurrent gastric GIST had a 44,XY-14,-22 karyotype and immunohistochemical evidence of strong diffuse cytoplasmic KIT expression without expression of actin, desmin, or S-100. Immunoblotting showed strong expression of phosphorylated KIT and downstream signaling intermediates (AKT and MAPK) at levels comparable with those reported in sporadic GISTs. cDNA array profiling demonstrated clustering with sporadic GISTs, and expression of GIST markers comparable to sporadic GISTs. CONCLUSION: These studies provide the first evidence that gene expression and mechanisms of cytogenetic progression and cell signaling are indistinguishable in familial and sporadic GISTs. Current investigations of molecularly targeted therapies in GIST patients provide opportunities to increase the understanding of features of the hereditary syndrome, and risk factors and molecular pathways of the neoplastic phenotypes. 相似文献
93.
Carl Morrison Michael Radmacher Nehad Mohammed David Suster Herbert Auer Susie Jones Judy Riggenbach Nicole Kelbick Gary Bos Joel Mayerson 《Journal of clinical oncology》2005,23(36):9369-9376
PURPOSE: To identify recurrent regions of genomic gain or loss in chondrosarcoma in a clinically relevant and statistically valid fashion. Materials and METHODS: Array comparative genomic hybridization (CGH) results of 15 frozen tumor samples of high-grade chondrosarcoma for chromosome 8 are presented. A separate subset of 116 cartilaginous tumors with outcome data was used for validation. RESULTS: Array CGH identified gain at 8q24.12-q24.13, the region of the MYC (c-Myc) oncogene, as a frequent change in high-grade chondrosarcoma. In the validation arm of 116 cartilaginous tumors, MYC was frequently amplified in G2 (15%), G3 (20%), and dedifferentiated (21%) chondrosarcomas. No amplification was identified in samples of enchondroma and grade 1 chondrosarcoma. In samples without MYC amplification, polysomy 8 was a frequent finding in grade 1 (18%), grade 2 (31%), grade 3 (80%), and dedifferentiated (29%) chondrosarcomas, but was not found in any samples of enchondroma. MYC protein expression was identified in all samples with amplification, but was also frequent in the remaining samples without amplification or polysomy 8. Kaplan-Meier survival curves for overall survival showed a statistically significant difference for patients with MYC amplification or polysomy 8 (P = .034). Univariate analysis involving Cox proportional hazards models showed that grade (P = .003), polysomy 8 (P = .045), and MYC amplification (P = .053) correlated with shorter overall survival. By multivariate analysis, grade of chondrosarcoma (P = .026) was the only factor to reach statistical significance. CONCLUSION: MYC amplification and polysomy 8 can be used as markers of prognostic importance in chondrosarcoma. Molecular targeting of MYC expression may have therapeutic potential in the future for subsets of chondrosarcoma. 相似文献
94.
Sharon K Krueger Lisbeth K Siddens Sarah R Martin Zhen Yu Clifford B Pereira Erwin T Cabacungan Ronald N Hines Kristin G Ardlie Judy L Raucy David E Williams 《Drug metabolism and disposition》2004,32(12):1337-1340
A polymorphism for the phase I drug-metabolizing enzyme, flavin-containing monooxygenase isoform 2 (FMO2), encoding either truncated inactive protein, FMO2X472 (FMO2.2A), or full-length active enzyme, FMO2Q472 (FMO2.1), is known and exhibits significant interethnic differences in allelic frequency. FMO2 is the major or sole FMO isoform expressed in the lung of most mammals, including nonhuman primates. To date, FMO2.1 has been found only in African-American and Hispanic populations, rendering individuals with this allele subject to drug metabolism that is potentially different from that of the general population. Approximately 26% of African-Americans (n = 180) possess the FMO2*1 allele. In preliminary studies, we initially estimated that 5% of Hispanics (n = 40) have the FMO2*1 allele, but access to large cohorts of individuals of defined national origin has allowed us to determine the occurrence among Mexican-American and Puerto Rican-American groups. We used allele-specific genotyping to detect FMO2*1 from 632 Hispanic individuals, including 280 individuals of Mexican origin and 327 individuals of Puerto Rican origin. Statistical analysis indicated that results from Mexican (five sample sources) and Puerto Rican (three sample sources) samples were consistent with the hypothesis of homogeneity within each group from different sources. Data were subsequently pooled across sources to test for evidence of a difference in occurrence of FMO2*1 between ethnic groups. There was strong evidence (p = 0.0066) that FMO2*1 is more common among Puerto Ricans (7%) than among individuals of Mexican descent (2%). The overall occurrence of FMO2*1 among Hispanics of all origins is estimated to be between 2 and 7%. 相似文献
95.
96.
Jiang Liu Minghui Zheng Wuyang Yang Sheng-fu L. Lo Judy Huang 《Journal of neuro-oncology》2018,138(3):609-617
Cerebral radiation necrosis (CRN) is a known complication of radiation therapy. Treatment options are limited and include steroids, bevacizumab, and surgery. This study seeks to determine the safety of laser interstitial thermal therapy (LITT) for CRN and identify the pattern of post-ablation volume change over time. Patients undergoing LITT for tumor treatment at Henry Ford Hospital between November 2013 and January 2016 with biopsy-confirmed CRN were prospectively collected and retrospectively reviewed with attention to ablation volume, survival, demographic data, steroid dose, and complications. Imaging occurred at set intervals beginning pre-ablation. Ten patients with 11 ablations were evaluated. Four patients had a primary diagnosis of high-grade glioma, while six had metastatic lesions. An average of 86% of CRN volume was ablated. Ablation volume increased to 430% of initial CRN volume at 1–2 weeks before decreasing to 69% after 6 months. No patient had a decline in baseline neurological examination while in the hospital. Four patients developed delayed neurological deficits likely due to post-operative edema, of which three improved back to baseline. The 6-month survival was 77.8% and the 1-year survival was 64.8% based on Kaplan–Meier curve estimates. In this study, LITT was a relatively safe treatment for CRN, providing both a diagnostic and therapeutic solution for refractory patients. Significant increase in ablation volume was noted at 1–2 months, gradually decreasing in size to less than the original volume by 6 months. Further studies are needed to better define the role of LITT in the treatment of CRN. 相似文献
97.
Hanin Rashid Robert Lebeau Norma Saks Anthony R. Artino Judy A. Shea 《Teaching and learning in medicine》2016,28(4):353-357
This Conversation Starters article presents a selected research abstract from the 2016 Association of American Medical Colleges Northeast Region Group on Educational Affairs annual spring meeting. The abstract is paired with the integrative commentary of three experts who shared their thoughts stimulated by the pilot study. These thoughts explore the metacognitive, social, and environmental mechanisms whereby advice plays a role in self-regulated learning. 相似文献
98.
Ashley D Willoughby Andrew T Schlussel Judy H Freeman Kevin Lin-Hurtubise 《Hawai'i Journal of Medicine & Public Health》2013,72(2):45-48
A case report of a 38-year-old man with a 10 year history of left buttock mass associated with pain and numbness. A computed tomography scan showed a subcutaneous enhancing 1cm lesion that was not communicating with surrounding structures to include neurovascular structures. The mass was removed without complication and sent to pathology for extensive review. This case report signifies the importance of maintaining a broad differential with a subcutaneous mass presentation and includes thorough histology and pathology for angioleiomyoma. 相似文献
99.
100.
Colin T. Jenney Judy R. Wilson Jeffrey N. Swanson Linda I. Perrotti Angela Liegey Dougall 《Journal of Applied Biobehavioral Research》2013,18(4):198-217
To explore methods of promoting physical activity, research was conducted to determine whether exergame use could serve as a gateway to future physical activity and to test its efficacy as an intervention. Undergraduates (n = 103) received introductory training during weeks 0–4 through a racquetball videogame (exergame), traditional training, or no‐exposure (control group). All groups then participated in the same, traditional training for weeks 5–8. No differences existed between the exergame and traditional training groups for most outcomes. Both groups increased over time in most outcomes and showed greater skills test performance at post‐intervention assessments than the control group. However, baseline physical activity moderated these outcomes. These results provide partial support for a gateway mechanism and guidelines for future research. 相似文献